148 related articles for article (PubMed ID: 8751588)
1. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
[TBL] [Abstract][Full Text] [Related]
2. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells.
Burghardt B; Barabás K; Marcsek Z; Flautner L; Gress TM; Varga G
J Physiol Paris; 2000; 94(1):57-62. PubMed ID: 10761690
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro.
Fisher WE; Wu Y; Amaya F; Berger DH
J Surg Res; 2002 Jun; 105(1):58-64. PubMed ID: 12069503
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
7. The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines.
Georgii-Hemming P; Strömberg T; Janson ET; Stridsberg M; Wiklund HJ; Nilsson K
Blood; 1999 Mar; 93(5):1724-31. PubMed ID: 10029602
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Radulovic S; Nagy A; Szoke B; Schally AV
Cancer Lett; 1992 Mar; 62(3):263-71. PubMed ID: 1317746
[TBL] [Abstract][Full Text] [Related]
9. The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
Zhou G; Gingras MC; Liu SH; Li D; Li Z; Catania RL; Stehling KM; Li M; Paganelli G; Gibbs RA; Demayo FJ; Fisher WE; Brunicardi FC
World J Surg; 2011 Aug; 35(8):1715-24. PubMed ID: 21249361
[TBL] [Abstract][Full Text] [Related]
10. Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers.
Kikutsuji T; Harada M; Tashiro S; Ii S; Moritani M; Yamaoka T; Itakura M
J Hepatobiliary Pancreat Surg; 2000; 7(5):496-503. PubMed ID: 11180877
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
Mishima M; Yano T; Jimbo H; Yano N; Morita Y; Yoshikawa H; Schally AV; Taketani Y
Am J Obstet Gynecol; 1999 Sep; 181(3):583-90. PubMed ID: 10486467
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.
Upp JR; Olson D; Poston GJ; Alexander RW; Townsend CM; Thompson JC
Am J Surg; 1988 Jan; 155(1):29-35. PubMed ID: 2893555
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogs for diagnosis and treatment of cancer.
Weckbecker G; Raulf F; Stolz B; Bruns C
Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
[TBL] [Abstract][Full Text] [Related]
17. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.
Rogers BE; McLean SF; Kirkman RL; Della Manna D; Bright SJ; Olsen CC; Myracle AD; Mayo MS; Curiel DT; Buchsbaum DJ
Clin Cancer Res; 1999 Feb; 5(2):383-93. PubMed ID: 10037188
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
Zhao B; Zhao H; Zhao N; Zhu XG
J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
Vidal C; Rauly I; Zeggari M; Delesque N; Esteve JP; Saint-Laurent N; Vaysse N; Susini C
Mol Pharmacol; 1994 Jul; 46(1):97-104. PubMed ID: 8058063
[TBL] [Abstract][Full Text] [Related]
20. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.
Liehr RM; Melnykovych G; Solomon TE
Gastroenterology; 1990 Jun; 98(6):1666-74. PubMed ID: 2186957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
